Global Alliance For Tb Drug Development
Clinical trials sponsored by Global Alliance For Tb Drug Development, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New TB cocktail aims to shorten treatment Results expected May 2027 (estimated)
-
Can a 4-Drug combo cut TB treatment time in half?
Disease control CompletedThis trial tests a new combination of four drugs, called BPaMZ, for treating tuberculosis. People with drug-sensitive TB receive BPaMZ for 4 months, compared to the standard 6-month regimen. People with drug-resistant TB receive BPaMZ for 6 months. The study measures how well the…
Phase 2/3 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug cocktail shows promise against Drug-Resistant TB
Disease control CompletedThis study tested a combination of three drugs—bedaquiline, pretomanid, and linezolid—in 109 people with extensively drug-resistant TB (XDR-TB) or multi-drug resistant TB (MDR-TB) that didn't respond to other treatments. Participants took the drugs for 6 to 9 months. The goal was…
Phase 3 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Jun 26, 2026 14:29 UTC